{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:59:08Z","timestamp":1768013948273,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":1009,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"DOI":"10.1002\/ejhf.2808","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:44:02Z","timestamp":1677199442000},"page":"525-527","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Variant and Wild Type Transthyretin Amyloidosis: Two Sides of the Same Coin or Different Currencies in Different Pockets?"],"prefix":"10.1093","volume":"25","author":[{"given":"Osnat","family":"Itzhaki Ben Zadok","sequence":"first","affiliation":[{"name":"Brigham and Women's Hospital Amyloidosis Program and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]},{"name":"Sackler School of Medicine, Tel-Aviv University , Tel-Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney H.","family":"Falk","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital Amyloidosis Program and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"2026010913083700600_ejhf2808-bib-0001","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"key":"2026010913083700600_ejhf2808-bib-0002","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026010913083700600_ejhf2808-bib-0003","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026010913083700600_ejhf2808-bib-0004","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaccao.2021.08.007","article-title":"Effect of tafamidis on serum transthyretin levels in non-trial patients with transthyretin amyloid cardiomyopathy","volume":"3","author":"Falk","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2026010913083700600_ejhf2808-bib-0005","doi-asserted-by":"crossref","first-page":"fcz032","DOI":"10.1093\/braincomms\/fcz032","article-title":"Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy","volume":"1","author":"Fernandes","year":"2019","journal-title":"Brain Commun"},{"key":"2026010913083700600_ejhf2808-bib-0006","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/jnc.15162","article-title":"A low amyloidoigenic E61K transthyretin mutation may cause familial amyloid polyneuropathy","volume":"156","author":"Murakami","year":"2021","journal-title":"J Neurochem"},{"key":"2026010913083700600_ejhf2808-bib-0007","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010913083700600_ejhf2808-bib-0008","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1742-4658.2007.05712.x","article-title":"Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration","volume":"274","author":"Hou","year":"2007","journal-title":"FEBS J"},{"key":"2026010913083700600_ejhf2808-bib-0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/14656566.2018.1554648","article-title":"An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy","volume":"20","author":"Plant\u00e9-Bordeneuve","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl K","key":"2026010913083700600_ejhf2808-bib-0010","first-page":"K224","article-title":"Primary results from APOLLO-B, a phase 3 study of patisiran in patients with transthyretin-mediated amyloidosis with cardiomyopathy","volume":"24","author":"Longhi","year":"2022","journal-title":"Eur Heart J Suppl"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejhf.2808","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ejhf.2808","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/4\/525\/65562060\/eurjhf_25_4_525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/25\/4\/525\/65562060\/eurjhf_25_4_525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:10:34Z","timestamp":1767982234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/25\/4\/525\/8341742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.2808","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"2023-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}